Sentinel lymph node biopsy in breast cancer: predictors of axillary and non-sentinel lymph node involvement. 2013

Hakan Postacı, and Baha Zengel, and Ulkem Yararbaş, and Adam Uslu, and Nuket Eliyatkın, and Göksever Akpınar, and Fevzi Cengiz, and Raika Durusoy
Department of Pathology, Turkish Ministry of Health İzmir Bozyaka Research and Training Hospital, İzmir, Turkey.

BACKGROUND Sentinel lymph node biopsy is a standard method for the evaluation of axillary status in patients with T1-2N0M0 breast cancers. OBJECTIVE To determine the prognostic significance of primary tumour-related clinico-histopathological factors on axillary and non-sentinel lymph node involvement of patients who underwent sentinel lymph node biopsy. METHODS Retrospective clinical study. METHODS In the present study, 157 sentinel lymph node biopsies were performed in 151 consecutive patients with early stage breast cancer between June 2008 and December 2011. RESULTS Successful lymphatic mapping was obtained in 157 of 158 procedures (99.4%). The incidence of larger tumour size (2.543±1.21 vs. 1.974±1.04), lymphatic vessel invasion (70.6% vs. 29.4%), blood vessel invasion (84.2% vs. 15.8%), and invasive lobular carcinoma subtype (72.7% vs. 27.3%) were statistically significantly higher in patients with positive SLNs. Logistic stepwise regression analysis disclosed tumour size (odds ratio: 1.51, p=0.0021) and lymphatic vessel invasion (odds ratio: 4.68, p=0.001) as significant primary tumour-related prognostic determinants of SLN metastasis. CONCLUSIONS A close relationship was identified between tumour size and lymphatic vessel invasion of the primary tumour and axillary lymph node involvement. However, the positive predictive value of these two independent variables is low and there is no compelling evidence to recommend their use in routine clinical practice.

UI MeSH Term Description Entries

Related Publications

Hakan Postacı, and Baha Zengel, and Ulkem Yararbaş, and Adam Uslu, and Nuket Eliyatkın, and Göksever Akpınar, and Fevzi Cengiz, and Raika Durusoy
December 2022, Archives of gynecology and obstetrics,
Hakan Postacı, and Baha Zengel, and Ulkem Yararbaş, and Adam Uslu, and Nuket Eliyatkın, and Göksever Akpınar, and Fevzi Cengiz, and Raika Durusoy
October 2001, American journal of surgery,
Hakan Postacı, and Baha Zengel, and Ulkem Yararbaş, and Adam Uslu, and Nuket Eliyatkın, and Göksever Akpınar, and Fevzi Cengiz, and Raika Durusoy
May 2007, Journal de gynecologie, obstetrique et biologie de la reproduction,
Hakan Postacı, and Baha Zengel, and Ulkem Yararbaş, and Adam Uslu, and Nuket Eliyatkın, and Göksever Akpınar, and Fevzi Cengiz, and Raika Durusoy
November 2005, Annals of surgical oncology,
Hakan Postacı, and Baha Zengel, and Ulkem Yararbaş, and Adam Uslu, and Nuket Eliyatkın, and Göksever Akpınar, and Fevzi Cengiz, and Raika Durusoy
February 2015, World journal of clinical oncology,
Hakan Postacı, and Baha Zengel, and Ulkem Yararbaş, and Adam Uslu, and Nuket Eliyatkın, and Göksever Akpınar, and Fevzi Cengiz, and Raika Durusoy
October 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
Hakan Postacı, and Baha Zengel, and Ulkem Yararbaş, and Adam Uslu, and Nuket Eliyatkın, and Göksever Akpınar, and Fevzi Cengiz, and Raika Durusoy
November 2002, Nihon Geka Gakkai zasshi,
Hakan Postacı, and Baha Zengel, and Ulkem Yararbaş, and Adam Uslu, and Nuket Eliyatkın, and Göksever Akpınar, and Fevzi Cengiz, and Raika Durusoy
January 2002, Breast cancer (Tokyo, Japan),
Hakan Postacı, and Baha Zengel, and Ulkem Yararbaş, and Adam Uslu, and Nuket Eliyatkın, and Göksever Akpınar, and Fevzi Cengiz, and Raika Durusoy
October 2010, The American surgeon,
Hakan Postacı, and Baha Zengel, and Ulkem Yararbaş, and Adam Uslu, and Nuket Eliyatkın, and Göksever Akpınar, and Fevzi Cengiz, and Raika Durusoy
December 2005, Journal of surgical oncology,
Copied contents to your clipboard!